About
Live-attenuated vaccine design technology
Areas of Focus
Categories
Virus TechnologyVaccineNJ, NY, PA
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
382
By Phase
PHASE1: 8
By Status
COMPLETED: 6ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04919109Lead Sponsor
Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children
PHASE1Active, not recruiting
51 participants
Started: Mar 28, 2023 · Completed: Aug 27, 2025
NCT05600582Lead Sponsor
A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer
PHASE1Withdrawn
Started: Jan 15, 2023 · Completed: Jan 30, 2025
NCT05233826Lead Sponsor
Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19
PHASE1Completed
20 participants
Started: Apr 14, 2022 · Completed: Dec 22, 2022
NCT05223179Lead Sponsor
Intramuscular CodaVax-H1N1 in Healthy Adults
PHASE1Completed
69 participants
Started: Apr 11, 2022 · Completed: Feb 9, 2024
NCT04619628Lead Sponsor
Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19
PHASE1Completed
48 participants
Started: Dec 11, 2020 · Completed: May 30, 2022
Funding History (1)
D
Feb 27, 2023
Locations (1)
Headquarters
Farmingdale, NY, United States
Map
Loading map...